Anti-Metallothionein IgG and levels of metallothionein in autistic families

Swiss Medical Weekly

Volumn 138, Issue 5-6, 2008, Pages 70-77

  Russo, Anthony J ^a  

^a MOUNT ST MARY S UNIVERSITY   (United States)

Author keywords

Anti metallothionein antibodies; Autism; Metallothionein

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; METALLOTHIONEIN; ZINC;

ALLERGY; ARTICLE; AUTISM; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT DISEASE; WESTERN BLOTTING;

EID: 39149092373     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington D.C.: American Psychiatric Association.
2. Gillberg C, Coleman M. 1992. The Biology of the Autistic Syndromes, 2nd edn. London: Mac Keith Press.
3. Filipek P, Accardo P, Baranek G, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29(6):439-84.
4. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuro-psychological, and neurobiological perspectives. J Child Psychol Psychiatry. 1996;37(1):89-126.
5. Suzuki T, Takemoto TI, Kashiwazaki H, Miyama T. Metabolic fate of ethylmercury salts in man and animal. Mercury, Mercurials, and Mercaptans , Miller M. W., Clarkson T. W., eds. Springfield: Charles C. Thomas. 1973;12:209-33.
6. Halsey N. A. 1999. Perspective on the use of thimerosalcontaining vaccines. Presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines, August 11-12. Institute of Vaccine Safety website: www.vaccinesafety.edu.
7. Egan WM. 1999.Thimerosal in Vaccines. Presentation to the FDA, September 14.
8. Davis LE, Kornfeld M, Mooney HS, et al. Methylmercury poisoning: long term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol. 1994;35(6):680-8.
9. Bernard S, Enayati A, Roger H, Binstock T, Redwood T, McGinnis W. 2000. Autism: "A Unique Type of Mercury Poisoning," ARC Research report, April.
10. Schubert J, Riley E, Tyler S. Combined Effects in Toxicology, a Rapid Systemic Testing Procedure: Cadmium, Mercury and Lead. J Toxicol Environ Health. 1978;4:763-76.
11. Goering PL, Klaassen CD. 1995. Hepatotoxicity of metals. In: Metals Toxicology, Academic Press, San Diego. p. 339-61.
12. Klaassen CD, Habeebu SSM. 1998. Role of metallothionein in cadmium-induced hepatotoxicity. Trends in Biopharmaceutical and Toxicological Sciences. (Ed), S.K. Lee and Y-J Surh, Seoul National University Press, Seoul, p. 1-17.
13. Takeda A, Kodama Y, Okada S. Metallothionein induction in rat brain after intrastriatal injection of zinc and cadmium salts. J Health Sci. 1999;45:20-3.
14. Koizumi S, Suzuki K, Ogra Y, Gong P, Otuska F. Roles of zinc fingers and other regions of the transcription factor human MTF-1 in zinc-regulated DNA binding. J Cell Physiol. 2000;185:464-72.
15. Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush AI. Metallothioneins in brain - the role in physiology and pathology. Toxicol Appl Pharmacol. 1997;142:229-42.
16. Goering PL, Klaassen CD. Hepatotoxicology of copper, iron, and cadmium. Compr Toxicol. 1997;9:389-406.
17. Cherian MG, Chan HM. Biological functions of metallothionein - a review. In: Metallothionein III, Suzuki, K.T., N. Imura, and M. Kimura, Eds. Birkhauser Verlag, Basel, 1993; p. 87-109.
18. Heijnen CJ, Treffers PDA. Autism and the immune system. J Child Psycol Psychiat. 1997;38(3):337-49.
19. Hu H, et al. Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology. 1999.
20. Walsh W, Usman A. 2001. Metal Metabolism and Autism at the American Psychiatric Association Annual Meeting, May 10, in New Orleans.
21. Grider A, et al. Zinc as main MT regulator Proc Nat Acad Sci 1990;87:1259-62.
22. Warren R, Odell J, Warren W, Burger R, Maciulis A, Daniels W, Torres A. "Immunoglobulin A deficiency in a subset of autistic subjects." J Autism Develop Dis. 1997;27:187-92.
23. Warren R, Margaretten N, Pace N, Foster A: "Immune abnormalities in patients with autism." J Autism Develop Dis. 1986;16:189-97.
24. Warren R, Singh V, Cole P, Odell J, Pingree C, Warren L, et al. "Possible association of the extended MHC haplotype B44-SC30-DR4 with autism." Immunogenetics. 1992;36:203-7.
25. Warren R, Yonk J, Burger R, Odell J, Warren W. "DR positive T cells in autism: association with decreased plasma levels of the complement C4B protein." Neuropsychobiology. 1995;31:53-7.
26. Gupta S, Aggarwal, Heads C. "Dysregulated immune system in children with autism. Beneficial effects of intravenous immune globulin on autistic characteristics." Autism Develop Dis. 1996;26:439-52.
27. Bagenstose LM, et al. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res. 1999;20(10):67-78.
28. Comi AM, et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14:388-94.
29. Singh VK, Hanson J. Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatr Allergy Immunol. 2006;17:291-6.
30. Jin GB, et al. High positive frequency of antibodies to metallothionein and heat shock protein 70 in sera of patients with metal allergy. Clin Exp Immunol. 2003;131:275-9.
31. Singh VK, Hanson J. (2005). Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatr Allergy Immunol. doi:10.1111/j.1399-3038. 2005.00348.x.